Tomoverse Imaging筹集了365万美元以推进心脏平台的发展-动脉网

Tomoverse Imaging raises $3.65m to advance cardiac platform

Medical Device Network 等信源发布 2025-07-14 08:19



可切换为仅中文







The company is focused on advancing cardiac CT imaging solutions intended for structural heart and coronary interventions. Credit: superbeststock / Shutterstock.

公司专注于推进用于结构性心脏和冠状动脉介入的心脏CT成像解决方案。图片来源：superbeststock / Shutterstock。

Canada-based medical software company Tomoverse Imaging has closed its seed funding round, securing C$5m ($3.65m), for the development of tvCT, a platform aimed at enhancing the planning and execution of complex transcatheter cardiac procedures.

总部位于加拿大的医疗软件公司Tomoverse Imaging已经完成了其种子轮融资，筹集了500万加元（365万美元），用于开发tvCT平台，该平台旨在改进复杂经导管心脏手术的规划和执行。

A significant Canadian Family Office spearheaded the seed funding round.

一家重要的加拿大家族理财办公室牵头了种子轮融资。

Go deeper with GlobalData

深入探索GlobalData

Reports

报告

Artificial Intelligence in Healthcare: Cellular Imaging Techniques

医疗保健领域的人工智能：细胞成像技术

Reports

报告

Artificial Intelligence in Healthcare: Ophthalmic Imaging System

医疗领域的人工智能：眼科成像系统

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多

This platform is said to offer intuitive cloud-based tools that aid clinicians in improving patient care and procedural outcomes, as well as support interventional cardiology research.

该平台据说提供了直观的基于云的工具，可以帮助临床医生改善患者护理和手术结果，并支持介入心脏病学研究。

It will integrate AI-based automated capabilities, enhancing accuracy in clinical workflows.

它将整合基于人工智能的自动化功能，提高临床工作流程的准确性。

The capital injection will support the company in progressing clinical trials and obtaining clearances from Health Canada, the US Food and Drug Administration (FDA), and other regulatory authorities worldwide.

资本注入将支持公司推进临床试验，并获得加拿大卫生部、美国食品和药物管理局 (FDA) 以及其他全球监管机构的批准。

In addition, the funds will bolster the company’s strategic commercialisation efforts in North America and prime international markets.

此外，这笔资金将加强该公司在北美和主要国际市场的战略商业化努力。

GlobalData Strategic Intelligence

全球数据战略情报

US Tariffs are shifting - will you react or anticipate?

美国关税正在变化——你会做出反应还是提前预测？

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

不要让政策变化让你措手不及。通过实时数据和专家分析保持主动性。

By GlobalData

由GlobalData提供

Learn more about Strategic Intelligence

了解有关战略情报的更多信息

Tomoverse Imaging CEO Stuart Kozlick said: “We are deeply grateful for the trust and confidence placed in us by our investors.

Tomoverse Imaging首席执行官Stuart Kozlick表示：“我们深深感谢投资者对我们的信任和信心。

“This strategic investment accelerates our product roadmap, enabling us to bring our innovative technology closer to patients and clinicians who need it most.”

“这项战略投资加速了我们的产品路线图，使我们能够将创新技术带给最需要它的患者和临床医生。”

The tvCT platform, which enables quick analysis of cardiac CT [computed tomography] images, has been designed to provide real-time results and is not yet granted approval for sale in any location.

tvCT平台能够快速分析心脏CT（计算机断层扫描）图像，旨在提供实时结果，但尚未在任何地方获得销售批准。

The software’s user-friendly design and customisable features allow for easy access and adaptation to certain clinical requirements.

该软件的用户友好设计和可定制功能使得满足特定临床需求变得容易。

Tomoverse emphasises the security of patient data, ensuring that its cloud-based platform adheres to the highest security standards.

Tomoverse 强调患者数据的安全性，确保其基于云的平台符合最高的安全标准。

It focuses on advancing cardiac CT imaging solutions intended for structural heart and coronary interventions.

它专注于推进用于结构性心脏病和冠状动脉介入治疗的心脏CT成像解决方案。

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

通过我们领先的行业洞察，为您的业务提供优势。

Medical Device Network Excellence Awards - Have you nominated?

医疗器械网络卓越奖——您提名了吗？